The inactivation of cyclin‐dependent kinase 2 (CDK2) effectively overcomes the blocking of cell differentiation in acute myeloid leukemia (AML) and is therefore a promising and potential approach for the treatment of AML.294. The gene discussed is CDK2; the disease is acute myeloid leukemia.